Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.
Who will be affected?
Readers: No access to all 28 journals. We recommend accessing our articles via PubMed Central
Authors: No access to the submission form or your user account.
Reviewers: No access to your user account. Please download manuscripts you are reviewing for offline reading before Wednesday, July 01, 2020 at 7:00 PM.
Editors: No access to your user account to assign reviewers or make decisions.
Copyeditors: No access to user account. Please download manuscripts you are copyediting before Wednesday, July 01, 2020 at 7:00 PM.
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Small extracellular vesicles in sarcoma patients follow-up: a pilot study
Valentin Vautrot;
Céline CHARON-BARRA;
Alice Hervieu;
Aurélie Bertaut;
Isen Naiken;
Emilie Rederstoff;
Nicolas Isambert;
Jessica Gobbo
ABSTRACT
Background:
Sarcomas are rare cancer with heterogeneous group of tumours. Metastasis is often fatal, and current prognostic methods are limited. Recent findings show that sarcoma cells release small extracellular vesicles. Studying them can help assess cancer development, progression, and treatment effectiveness. This study aims to demonstrate the potential of small extracellular vesicles for monitoring the disease and predicting recurrence risk.
Methods:
A multicentric, prospective pilot study that will include 30 adults’ patients with localized or metastatic sarcoma. Small extracellular vesicles will be isolated from blood samples and protein and miRNA concentration will be determined. Research will last, on average, 6 months for patients with localized sarcoma and 4 months for patients with metastatic sarcoma. The study is sponsored by the Georges-François Leclerc Center and is currently ongoing.
Discussion: Our innovative approach could improve sarcoma patient management through a non-invasive technique to predict treatment response and/or disease progression.
Trial Registration: ClinicalTrials.gov identifier NCT03800121. Registered January 11, 2019, https://clinicaltrials.gov/ct2/show/study/NCT03800121
Keywords: Pilot-study, liquid biopsy, exosomes, sarcoma, cancer monitoring.
Citation
Please cite as:
Vautrot V, CHARON-BARRA C, Hervieu A, Bertaut A, Naiken I, Rederstoff E, Isambert N, Gobbo J
Small Extracellular Vesicles as Biomarkers in Sarcoma Follow-Up: Protocol for a Prospective, Multicentric Pilot Study